On Sept. 24, the U.S. Department of Commerce launched a Section 232 National Security Investigation into medical product imports, which:
  • will assess whether U.S. reliance on medical product imports poses a national security risk
  • may result in additional tariffs — any 232 tariffs would be added on top of existing tariffs
We need a diverse group of stakeholders to weigh in on this issue by Friday, October 17, 2025 at 11:59pm ET.

Step 1: Prepare Your Letter

  1. A sample template is available below.
  2. Focus on the impact: Your comments should clearly explain how potential tariffs on medical products would affect your operations and patient care.
Sample Template

Web Version Download (Microsoft Word)


Step 2: Navigate To Regulations.Gov

The button below will take you directly to the comment submission page for “Section 232 Medical PPE and Equipment (Document ID BIS-2025-0258-0001).

Go To Comments Page

  1. Required: Under the Comment prompt, type (or copy-paste) your comment submission.
    Even if you prefer to upload your letter, you MUST type something in the comment box.
    Comment prompt
  2. Required: Identify whether your comments are from you as an individual or on behalf of an organization (whichever is appropriate).
    You will be prompted to enter additional information once you select the most appropriate option.
  3. Required: Follow the reCAPTCHA instructions and click the blue “Submit Comment” button at the bottom of the page.
    The button will only turn dark blue when all required fields are complete.
    Submit Comment button

Sample Comment Letter

Download (Microsoft Word)

Re: Section 232 National Security Investigation into Medical Products

Dear Secretary Lutnick:

I am writing on behalf of [Your Organization's Name], a [Hospital, Community Health Center, Physician Group, etc.] dedicated to providing high-quality, accessible care to patients in [Your City/State]. As frontline providers, we are concerned that potential Section 232 tariffs on medical products would impact the stability and cost of patient care.

Healthcare providers are already under considerable financial pressure. For us, this reality hits close to home as we struggle with reimbursement rates that aren't keeping pace with rising operational costs. Cuts in funding to government payors like Medicaid and Medicare make it increasingly difficult to deliver the high-quality care our patients deserve and expect. All financial pressures directly affect our ability to invest in staff, technology, and clinical services.

We are concerned that implementing Section 232 tariffs would also put unsustainable stress on supply availability. If essential supplies become less readily available, patient care and experience will be impacted.

Patient care can't wait while trade policies adjust. Access to medical products requires a resilient medical supply chain that can weather both foreign and domestic supply disruptions. Therefore, we respectfully urge you to consider the implications before moving forward with additional tariffs on critical medical products. Reliable, affordable access to medical products is fundamental to our ability to deliver continuous, quality healthcare.

Sincerely,

[Your Name]
[Your Title]
[Your Organization's Name]

Contact:

Wyeth Ruthven

Wyeth Ruthven
Director, Congressional & Public Relations
703-838-6128
ruthven@hida.org